//
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure